Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...

This study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...

Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.

Early animal studies have indicated that GLP-1 drugs can help cut alcohol cravings, but studies involving humans are only starting to emerge, researchers said. For this study, researchers tracked ...

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

Glucagon-like peptide-1 (GLP-1) analogues, drugs developed ... ‘effortless’.” The study’s limitations include the relatively small number of patients, the use of self-reported alcohol ...

lower-dose care model to U.S. employers seeking sustainability As GLP-1 adoption grows among U.S. employers, the study points to a path toward meaningful outcomes without escalating drug costs.

People booze a lot less when taking GLP-1 drugs like Ozempic, a new study out of Ireland ... statistics show. Monkey Business – stock.adobe.com Harmful alcohol use accounts for about 2.6 million ...

A new study indicates that certain GLP-1 weight-loss drugs can help ... Wegovy is approved for use in weight management. Semaglutide drugs are available as both oral tablets and injections.

A new study found that GLP-1 drugs significantly reduce cancer risk associated with obesity — even more so than getting weight loss surgery. REUTERS Published in the Lancet’s eClinicalMedicine ...

34,366 people played the daily Crossword recently. Can you solve it faster than others?34,366 people played the daily Crossword recently. Can you solve it faster than others?